Adenoviral infections in hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 3, 2006, Pages 243-251

  Leen, Ann M ^a   Bollard, Catherine M ^a   Myers, Gary D ^a   Rooney, Cliona M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Adenovirus; Hematopoietic stem cell transplantation; Immunotherapy

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS ANTIGEN PP65; EPSTEIN BARR VIRUS ANTIGEN; RIBAVIRIN;

ADENOVIRUS; ADENOVIRUS VECTOR; ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELLULAR IMMUNITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FATALITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION CONTROL; INNATE IMMUNITY; LEUKOCYTE; MORBIDITY; MORTALITY; NEPHROTOXICITY; NONHUMAN; POSTOPERATIVE PERIOD; RECIPIENT; REVIEW; TREATMENT FAILURE; VIRAL GENE THERAPY; VIRUS INFECTION;

ADENOVIRIDAE INFECTIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY, ADOPTIVE; MALE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33244475112     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.10.024     Document Type: Review

References (83)

1. A. Gaggar D.M. Shayakhmetov A. Lieber CD46 is a cellular receptor for group B adenoviruses Nat Med 9 2003 1408-1412
2. A. Gaggar D.M. Shayakhmetov M.K. Liszewski J.P. Atkinson A. Lieber Localization of regions in CD46 that interact with adenovirus J Virol 79 2005 7503-7513
3. N. Arnberg K. Edlund A.H. Kidd G. Wadell Adenovirus type 37 uses sialic acid as a cellular receptor J Virol 74 2000 42-48
4. D.M. Shayakhmetov Z.Y. Li V. Ternovoi A. Gaggar H. Gharwan A. Lieber The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses J Virol 77 2003 3712-3723
5. U.F. Greber M. Suomalainen R.P. Stidwill K. Boucke M.W. Ebersold A. Helenius The role of the nuclear pore complex in adenovirus DNA entry EMBO J 16 1997 5998-6007
6. U.F. Greber P. Webster J. Weber A. Helenius The role of the adenovirus protease on virus entry into cells EMBO J 15 1996 1766-1777
7. P.L. Leopold G. Kreitzer N. Miyazawa et al. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis Hum Gene Ther 11 2000 151-165
8. M. Suomalainen M.Y. Nakano S. Keller K. Boucke R.P. Stidwill U.F. Greber Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus J Cell Biol 144 1999 657-672
9. N. Miyazawa R.G. Crystal P.L. Leopold Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein J Virol 75 2001 1387-1400
10. N. Miyazawa P.L. Leopold N.R. Hackett et al. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors J Virol 73 1999 6056-6065
11. J.J. Rux R.M. Burnett Adenovirus structure Hum Gene Ther 15 2004 1167-1176
12. D.A. Muruve The innate immune response to adenovirus vectors Hum Gene Ther 15 2004 1157-1166
13. W.S. Wold K. Doronin K. Toth M. Kuppuswamy D.L. Lichtenstein A.E. Tollefson Immune responses to adenoviruses viral: Evasion mechanisms and their implications for the clinic Curr Opin Immunol 11 1999 380-386
14. P. Flomenberg V. Piaskowski R.L. Truitt J.T. Casper Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon J Virol 70 1996 6314-6322
15. W.S. Wold L.R. Gooding Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor Mol Biol Med 6 1989 433-452
16. W.S. Wold L.R. Gooding Region E3 of adenovirus a cassette of genes involved in host immunosurveillance and virus-cell interactions Virology 184 1991 1-8
17. L.G. Guidotti F.V. Chisari Noncytolytic control of viral infections by the innate and adaptive immune response Annu Rev Immunol 19 2001 65-91
18. C. Pasare R. Medzhitov Toll-like receptors: Linking innate and adaptive immunity Adv Exp Med Biol 560 2005 11-18
19. B. Heemskerk L.A. Veltrop-Duits T. van Vreeswijk et al. Extensive cross-reactivity of CD+ adenovirus-specific T cells implications for immunotherapy and gene therapy J Virol 77 2003 6562-6566
20. A.M. Leen U. Sili B. Savoldo et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications Blood 103 2004 1011-1019
21. M. Olive L. Eisenlohr N. Flomenberg S. Hsu P. Flomenberg The adenovirus capsid protein hexon contains a highly conserved human CD+ T-cell epitope Hum Gene Ther 13 2002 1167-1178
22. M. Olive L.C. Eisenlohr P. Flomenberg Quantitative analysis of adenovirus-specific CD+ T-cell responses from healthy adults Viral Immunol 14 2001 403-413
23. T. Kojaoghlanian P. Flomenberg M.S. Horwitz The impact of adenovirus infection on the immunocompromised host Rev Med Virol 13 2003 155-171
24. A. Allard R. Girones P. Juto G. Wadell Polymerase chain reaction for detection of adenoviruses in stool samples J Clin Microbiol 28 1990 2659-2667
25. M. Echavarria M. Forman J. Ticehurst J.S. Dumler P. Charache PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals J Clin Microbiol 36 1998 3323-3326
26. P. Pring-Akerblom T. Adrian Type- and group-specific polymerase chain reaction for adenovirus detection Res Virol 145 1994 25-35
27. P. Pring-Akerblom T. Adrian T. Kostler PCR-based detection and typing of human adenoviruses in clinical samples Res Virol 148 1997 225-231
28. B. Mercier L. Burlot C. Ferec Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay J Virol Methods 77 1999 1-9
29. T. Morris B. Robertson M. Gallagher Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system J Clin Microbiol 34 1996 2933-2936
30. A.J. Ryncarz J. Goddard A. Wald M.L. Huang B. Roizman L. Corey Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples J Clin Microbiol 37 1999 1941-1947
31. H.J. Wagner Y.C. Cheng M.H. Huls et al. Prompt versus preemptive intervention for EBV lymphoproliferative disease Blood 103 2004 3979-3981
32. A. Heim C. Ebnet G. Harste P. Pring-Akerblom Rapid and quantitative detection of human adenovirus DNA by real-time PCR J Med Virol 70 2003 228-239
33. T. Lion R. Baumgartinger F. Watzinger et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease Blood 102 2003 1114-1120
34. F. Morfin S. Dupuis-Girod S. Mundweiler et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent Antivir Ther 10 2005 225-229
35. A.M. Leen C.M. Rooney Adenovirus as an emerging pathogen in immunocompromised patients Br J Haematol 128 2005 135-144
36. A. Baldwin H. Kingman M. Darville et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation Bone Marrow Transplant 26 2000 1333-1338
37. S. Chakrabarti V. Mautner H. Osman et al. Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery Blood 100 2002 1619-1627
38. G.A. Hale H.E. Heslop R.A. Krance et al. Adenovirus infection after pediatric bone marrow transplantation Bone Marrow Transplant 23 1999 277-282
39. D.S. Howard G.L. Phillips II D.E. Reece et al. Adenovirus infections in hematopoietic stem cell transplant recipients Clin Infect Dis 29 1999 1494-1501
40. B. Kampmann D. Cubitt T. Walls et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation Br J Haematol 130 2005 595-603
41. V. Runde S. Ross R. Trenschel et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): Report on 130 patients from a single SCT unit involved in a prospective multicenter surveillance study Bone Marrow Transplant 28 2001 51-57
42. P. Flomenberg J. Babbitt W.R. Drobyski et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients J Infect Dis 169 1994 775-781
43. I. Avivi S. Chakrabarti D.W. Milligan et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab Biol Blood Marrow Transplant 10 2004 186-194
44. A.M. Leen U. Sili E.F. Vanin et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD+ T cells Blood 104 2004 2432-2440
45. C.A. Smith L.S. Woodruff C. Rooney G.R. Kitchingman Extensive cross-reactivity of adenovirus-specific cytotoxic T cells Hum Gene Ther 9 1998 1419-1427
46. T. Feuchtinger J. Lucke K. Hamprecht et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation Br J Haematol 128 2005 503-509
47. M.J. van Tol A.C. Kroes J. Schinkel et al. Adenovirus infection in paediatric stem cell transplant recipients: Increased risk in young children with a delayed immune recovery Bone Marrow Transplant 36 2005 39-50
48. T. Walls K. Hawrami I. Ushiro-Lumb D. Shingadia V. Saha A.G. Shankar Adenovirus infection after pediatric bone marrow transplantation: Is treatment always necessary? Clin Infect Dis 40 2005 1244-1249
49. P. Bordigoni A.S. Carret V. Venard F. Witz A. Le Faou Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation Clin Infect Dis 32 2001 1290-1297
50. P.J. Gavin B.Z. Katz Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children Pediatrics 110 2002 e9
51. J.A. Hoffman A.J. Shah L.A. Ross N. Kapoor Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation Biol Blood Marrow Transplant 7 2001 388-394
52. A.M. La Rosa R.E. Champlin N. Mirza et al. Adenovirus infections in adult recipients of blood and marrow transplants Clin Infect Dis 32 2001 871-876
53. F. Legrand D. Berrebi N. Houhou et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children Bone Marrow Transplant 27 2001 621-626
54. P. Ljungman P. Ribaud M. Eyrich et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: A survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 31 2003 481-486
55. A.C. Lankester B. Heemskerk E.C. Claas et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection Clin Infect Dis 38 2004 1521-1525
56. M. Leruez-Ville V. Minard F. Lacaille et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection Clin Infect Dis 38 2004 45-52
57. T. Feuchtinger P. Lang K. Hamprecht et al. Isolation and expansion of human adenovirus-specific CD+ and CD+ T cells according to IFN-gamma secretion for adjuvant immunotherapy Exp Hematol 32 2004 282-289
58. B. Heemskerk A.C. Lankester T. van Vreeswijk et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients J Infect Dis 191 2005 520-530
59. R. Hromas K. Cornetta E. Srour C. Blanke E.R. Broun Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation Blood 84 1994 1689-1690
60. P. Flomenberg V. Piaskowski R.L. Truitt J.T. Casper Characterization of human proliferative T cell responses to adenovirus J Infect Dis 171 1995 1090-1096
61. C.A. Smith L.S. Woodruff G.R. Kitchingman C.M. Rooney Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro J Virol 70 1996 6733-6740
62. S. Regn S. Raffegerst X. Chen D. Schendel H.J. Kolb M. Roskrow Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant Bone Marrow Transplant 27 2001 53-64
63. Y. Hamel N. Blake S. Gabrielsson et al. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: A novel approach for immunotherapy Hum Gene Ther 13 2002 855-866
64. V. Molinier-Frenkel R. Lengagne F. Gaden et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response J Virol 76 2002 127-135
65. J. Tang M. Olive K. Champagne et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele Gene Ther 11 2004 1408-1415
66. L. Crawford-Miksza D.P. Schnurr Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues J Virol 70 1996 1836-1844
67. P.A. Piedra G.A. Poveda B. Ramsey K. McCoy P.W. Hiatt Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: Implication for gene therapy with adenovirus vectors Pediatrics 101 1998 1013-1019
68. J.J. Rux P. Kuser R.M. Burnett Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods J Virol 77 2003 9553-9566
69. J.J. Rux R.M. Burnett Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon Mol Ther 1 2000 18-30
70. M.S. Horwitz Adenoviruses 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002 2301-2326
71. T.E. Shenk Adenoviridae: The Viruses and Their Replication 4th ed. 2002 Lippincott Williams & Wilkins Philadelphia 2265-2300
72. D.M. Shayakhmetov A. Lieber Dependence of adenovirus infectivity on length of the fiber shaft domain J Virol 74 2000 10274-10286
73. P. Yotnda H. Onishi H.E. Heslop et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus Gene Ther 8 2001 930-937
74. D.H. Busch E.G. Pamer T cell affinity maturation by selective expansion during infection J Exp Med 189 1999 701-709
75. J. Haanen M.C. Wolkers A.M. Kruisbeek T.N. Schumacher Selective expansion of cross-reactive CD+ memory T cells by viral variants J Exp Med 190 1999 1319-1328
76. C.M. Bollard I. Kuehnle A. Leen C.M. Rooney H.E. Heslop Adoptive immunotherapy for posttransplantation viral infections Biol Blood Marrow Transplant 10 2004 143-155
77. H.E. Heslop C.Y.C. Ng C. Li et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat Med 2 1996 551-555
78. S.R. Riddell B.A. Walter M.J. Gilbert P.D. Greenberg Selective reconstitution of CD+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cells clones Bone Marrow Transplant 14 1994 S78-S84
79. C.M. Rooney C.A. Smith C. Ng et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation Lancet 345 1995 9-13
80. C.M. Rooney C.A. Smith C.Y. Ng et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1998 1549-1555
81. E.A. Walter P.D. Greenberg M.J. Gilbert et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038-1044
82. H. Einsele E. Roosnek N. Rufer et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 99 2002 3916-3922
83. K.F. Kozarsky J.M. Wilson Gene therapy: Adenovirus vectors Curr Opin Genet Dev 3 1993 499-503